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The objective of this review was to understand the clinical utilization, utility, and variability 
in the usage of adjunctive hyperbaric oxygen therapy (HBOT). Surgical site infection is 
associated with high morbidity and mortality, increased health care expenditure, and 
decreased quality of life. With the increasing prevalence of adult spinal deformity and 
spinal fusion surgery, it is imperative to understand the potential benefits of adjunctive 
treatments. HBOT is a safe and common procedure indicated to treat various medical 
conditions. We conducted a literature search across 3 databases for English articles 
published between December 1, 2019 and December 1, 2000. Thirteen studies were 
included. HBOT may lessen the duration of antimicrobial therapy and mitigate instrument 
removal and revision surgery. The current usage indications for HBOT are supported by 
level III evidence for chronic osteomyelitis and level IV evidence for osteoradionecrosis. 
However, the same level of evidence exists to support the beneficial use of adjunctive 
HBOT for noncomplicated spinal infections within 2 months after surgery. When cultured, 
the most common organisms were Staphylococcus aureus and other low-virulence 
organisms. The most common treatment protocol consists of 90-minute sessions of 100% 
Fio2 at 2-3 atmosphere absolute with a mean of 35.3 ± 11.6 sessions for 5.2 ± 1.4 weeks. 
Adjunctive HBOT should be considered in select high-risk patients. Further improvements 
in diagnosis and categorization of spinal infections are necessary and will indelibly aid the 
decision making for the initiation of HBOT. 
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